Home » Authors » Cynthia Robbins-Roth

Articles by Cynthia Robbins-Roth

As The BioWorld Turns, Part II: Slimming Down With Brownies?

April 9, 2007

By Cynthia Robbins-Roth

As The BioWorld Turns, Part II: Slimming Down With Brownies?

April 9, 2007

By Cynthia Robbins-Roth

As Biotech Turns: Fumbling, Bumbling And Posh Spice

March 26, 2007

By Cynthia Robbins-Roth

As Biotech Turns: Fumbling, Bumbling And Posh Spice

March 26, 2007

By Cynthia Robbins-Roth

Location, Location, Location: Ceregene Bets on Better Delivery

March 12, 2007

By Cynthia Robbins-Roth

Location, Location, Location: Ceregene Bets on Better Delivery

March 12, 2007

By Cynthia Robbins-Roth

Getting Closer to Nature: The BrainCells Way

Feb. 26, 2007

By Cynthia Robbins-Roth

Getting Closer to Nature: The BrainCells Way

Feb. 26, 2007

By Cynthia Robbins-Roth

Is FIPCO Only Way To Go? Try Thinking 'Small Ball'

Feb. 12, 2007

By Cynthia Robbins-Roth

Is FIPCO Only Way To Go? Try Thinking 'Small Ball'

Feb. 12, 2007

By Cynthia Robbins-Roth

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 4, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
Phase III AMD miss leaves BLA Outlook same with bevacizumab
BioWorld
Outlook Therapeutics Inc. is forging onward with plans to resubmit the BLA for ONS-5010, an ophthalmic version of Avastin (bevacizumab, Roche AG), after a missed...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.